Paper Details

  1. Home
  2. Paper Details

Effects of enteric-coated, low-dose aspirin on parameters of platelet function.

Author: ArnoutJ, De HoonJ N, De LepeleireI, DepréM, DynderA, GottesdienerK, JulianoM L, PettyK J, Van HeckenA, WildongerL

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Enteric-coated, low-dose aspirin is effective in inhibiting serum generated thromboxane B2 and platelet aggregation in healthy subjects. The mean percentage inhibition of serum thromboxane B2 was 97.4% after 7 daily doses of enteric-coated aspirin.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Aspirin is widely used as an anti-thrombotic drug; however, it has been suggested that enteric-coated formulations of aspirin may be less bioavailable and less effective as anti-thrombotic agents. AIM: To assess the effect of a formulation of enteric-coated, low-dose (81 mg) aspirin on ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1365-2036.2002.01332.x

データ提供：米国国立医学図書館（NLM）

The Effectiveness of Enteric-Coated Aspirin for Platelet Inhibition

Aspirin, a widely used medication for preventing heart attacks and strokes, can be taken in different formulations. This study investigates the effectiveness of an enteric-coated, low-dose aspirin formulation for inhibiting platelet function. The researchers found that this formulation was as effective as regular aspirin in reducing platelet aggregation, indicating that it can be a safe and effective alternative for those who may experience stomach irritation with regular aspirin. It's like finding a hidden oasis in the vast desert of aspirin research, offering a more comfortable and equally effective way to navigate the path to cardiovascular health.

A Gentle Approach to Aspirin Therapy

This study provides evidence that enteric-coated, low-dose aspirin can effectively inhibit platelet function, offering a potentially gentler alternative for patients who may experience stomach irritation with regular aspirin. It's like finding a camel that can gracefully navigate the desert landscape, offering a more comfortable and effective way to reach your destination.

Choosing the Right Aspirin for Your Needs

The study's findings suggest that enteric-coated aspirin can be a suitable option for patients who may experience stomach irritation with regular aspirin. It's important to discuss any concerns you have about aspirin with your doctor, as they can help you choose the most appropriate formulation for your individual needs. Think of it as finding the right camel to guide you through the desert of aspirin therapy, ensuring a comfortable and effective journey towards better heart health.

Dr. Camel's Conclusion

This study offers valuable insights into the effectiveness of enteric-coated aspirin, providing evidence that it can be an effective and potentially gentler option for inhibiting platelet function. It's a reminder that the quest for better heart health requires a thorough understanding of the various treatment options available and the need for personalized care based on individual patient needs. Think of it as exploring a desert landscape, finding the perfect oasis of knowledge and care to support your health journey.
Date :
  1. Date Completed 2003-01-22
  2. Date Revised 2019-09-01
Further Info :

Pubmed ID

12197849

DOI: Digital Object Identifier

10.1046/j.1365-2036.2002.01332.x

Related Literature

Article Analysis
・Effects of aspirin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.